Colony stimulating factor-1 (CSF-1) signalling is predictive of response to immune checkpoint inhibitors in advanced non-small cell lung cancer

The identification of biomarkers related to treatment in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs) represents a significant challenge. The aim of this study was to determine the predictive value of macrophage-related markers assessed in plasma...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Lung cancer (Amsterdam, Netherlands) Netherlands), 2024-02, Vol.188, p.107447-107447, Article 107447
Hauptverfasser:	Takam Kamga, Paul, Mayenga, Marie, Sebane, Louise, Costantini, Adrien, Julie, Catherine, Capron, Claude, Parent, Florence, Seferian, Andrei, Guettier, Catherine, Emile, Jean-François, Giroux Leprieur, Etienne
Format:	Artikel
Sprache:	eng
Schlagworte:	Carcinoma, Non-Small-Cell Lung - drug therapy Humans Immune Checkpoint Inhibitors - therapeutic use Leukocytes, Mononuclear Life Sciences Lung Neoplasms - drug therapy Macrophage Colony-Stimulating Factor Prospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!